SUMO and the robustness of cancer
- PMID: 28134258
- DOI: 10.1038/nrc.2016.143
SUMO and the robustness of cancer
Abstract
Post-translational protein modification by small ubiquitin-like modifier (SUMO), termed sumoylation, is an important mechanism in cellular responses to stress and one that appears to be upregulated in many cancers. Here, we examine the role of sumoylation in tumorigenesis as a possibly necessary safeguard that protects the stability and functionality of otherwise easily misregulated gene expression programmes and signalling pathways of cancer cells.
Similar articles
-
NF-kappaB activation by combinations of NEMO SUMOylation and ATM activation stresses in the absence of DNA damage.Oncogene. 2007 Feb 1;26(5):641-51. doi: 10.1038/sj.onc.1209815. Epub 2006 Jul 24. Oncogene. 2007. PMID: 16862178
-
SUMOylation attenuates sensitivity toward hypoxia- or desferroxamine-induced injury by modulating adaptive responses in salivary epithelial cells.Am J Pathol. 2006 May;168(5):1452-63. doi: 10.2353/ajpath.2006.050782. Am J Pathol. 2006. PMID: 16651613 Free PMC article.
-
Emerging role of SUMO in pancreatic beta-cells.Horm Metab Res. 2007 Sep;39(9):658-64. doi: 10.1055/s-2007-985372. Horm Metab Res. 2007. PMID: 17846973 Review.
-
Small ubiquitin-related modifier-1 modification regulates all-trans-retinoic acid-induced differentiation via stabilization of retinoic acid receptor α.FEBS J. 2014 Jul;281(13):3032-47. doi: 10.1111/febs.12840. Epub 2014 Jun 2. FEBS J. 2014. PMID: 24819975
-
Progress of small ubiquitin-related modifiers in kidney diseases.Chin Med J (Engl). 2019 Feb;132(4):466-473. doi: 10.1097/CM9.0000000000000094. Chin Med J (Engl). 2019. PMID: 30707172 Free PMC article. Review.
Cited by
-
Poly-SUMO-2/3 chain modification of Nuf2 facilitates CENP-E kinetochore localization and chromosome congression during mitosis.Cell Cycle. 2021 May;20(9):855-873. doi: 10.1080/15384101.2021.1907509. Epub 2021 Apr 28. Cell Cycle. 2021. PMID: 33910471 Free PMC article.
-
Recent developments in epigenetic cancer therapeutics: clinical advancement and emerging trends.J Biomed Sci. 2021 Apr 12;28(1):27. doi: 10.1186/s12929-021-00721-x. J Biomed Sci. 2021. PMID: 33840388 Free PMC article. Review.
-
SUMOylation of TUFT1 is essential for gastric cancer progression through AKT/mTOR signaling pathway activation.Cancer Sci. 2023 Feb;114(2):533-545. doi: 10.1111/cas.15618. Epub 2022 Nov 15. Cancer Sci. 2023. PMID: 36380570 Free PMC article.
-
SENP1 mediates zinc-induced ZnT6 deSUMOylation at Lys-409 involved in the regulation of zinc metabolism in Golgi apparatus.Cell Mol Life Sci. 2024 Oct 5;81(1):422. doi: 10.1007/s00018-024-05452-4. Cell Mol Life Sci. 2024. PMID: 39367979 Free PMC article.
-
The SUMO protease SENP1 promotes aggressive behaviors of high HIF2α expressing renal cell carcinoma cells.Oncogenesis. 2022 Oct 25;11(1):65. doi: 10.1038/s41389-022-00440-4. Oncogenesis. 2022. PMID: 36284084 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources